Massachusetts General Hospital
This is a single-center, open-label pilot study to determine the effect of large area fractional laser treatment (LAFLT) on adults' metabolic profile.
The current research project aims to investigate the effects of large-area fractional laser treatment (LAFLT) on body weight, metabolism, and body composition. Prior research suggests that treating large skin areas with fractional laser therapy may stimulate metabolism and promote weight loss. The MIRIA laser, an FDA-approved fractional laser, is widely used for skin aging, acne scarring, and wrinkle reduction and will be used to evaluate these potential metabolic effects. Subjects aged 18-60 with a BMI of 25-30 will undergo three fractional laser treatments on the abdomen and thighs over 36…
Inclusion Criteria: 1. 18- 60 years of age; 2. BMI between 25.0 and 30 kg/m2; 3. Subjects must be in good general health, based on answers provided during the screening visit; 4. Subject must be able and willing to provide written informed consent and comply with the requirements of the study protocol. 5. Females of childbearing potential must be willing and able to use a medically highly effective form of birth control during the entire study. Exclusion Criteria: 1. Participation in another investigational drug or device clinical trial in the past 30 days; 2. Currently pregnant or pregnanc…
Three fractional laser treatments to the abdomen and thighs at 4 week intervals.
Arctuva estimate
Verify or correct the compensation shown for this listing.